214 related articles for article (PubMed ID: 12872363)
1. Evaluation of pain associated with oral mucositis during the acute period after administration of high-dose chemotherapy.
Cella D; Pulliam J; Fuchs H; Miller C; Hurd D; Wingard JR; Sonis ST; Martin PJ; Giles F
Cancer; 2003 Jul; 98(2):406-12. PubMed ID: 12872363
[TBL] [Abstract][Full Text] [Related]
2. A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.
Trotti A; Garden A; Warde P; Symonds P; Langer C; Redman R; Pajak TF; Fleming TR; Henke M; Bourhis J; Rosenthal DI; Junor E; Cmelak A; Sheehan F; Pulliam J; Devitt-Risse P; Fuchs H; Chambers M; O'Sullivan B; Ang KK
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):674-81. PubMed ID: 14967419
[TBL] [Abstract][Full Text] [Related]
3. A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy.
Giles FJ; Rodriguez R; Weisdorf D; Wingard JR; Martin PJ; Fleming TR; Goldberg SL; Anaissie EJ; Bolwell BJ; Chao NJ; Shea TC; Brunvand MM; Vaughan W; Petersen F; Schubert M; Lazarus HM; Maziarz RT; Silverman M; Beveridge RA; Redman R; Pulliam JG; Devitt-Risse P; Fuchs HJ; Hurd DD
Leuk Res; 2004 Jun; 28(6):559-65. PubMed ID: 15120931
[TBL] [Abstract][Full Text] [Related]
4. A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial).
Giles FJ; Miller CB; Hurd DD; Wingard JR; Fleming TR; Sonis ST; Bradford WZ; Pulliam JG; Anaissie EJ; Beveridge RA; Brunvand MM; Martin PJ;
Leuk Lymphoma; 2003 Jul; 44(7):1165-72. PubMed ID: 12916869
[TBL] [Abstract][Full Text] [Related]
5. Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting.
Stiff PJ; Emmanouilides C; Bensinger WI; Gentile T; Blazar B; Shea TC; Lu J; Isitt J; Cesano A; Spielberger R
J Clin Oncol; 2006 Nov; 24(33):5186-93. PubMed ID: 16391299
[TBL] [Abstract][Full Text] [Related]
6. Topical curcumin for the prevention of oral mucositis in pediatric patients: case series.
Elad S; Meidan I; Sellam G; Simaan S; Zeevi I; Waldman E; Weintraub M; Revel-Vilk S
Altern Ther Health Med; 2013; 19(3):21-4. PubMed ID: 23709456
[TBL] [Abstract][Full Text] [Related]
7. Low-level infrared laser therapy in chemotherapy-induced oral mucositis: a randomized placebo-controlled trial in children.
Kuhn A; Porto FA; Miraglia P; Brunetto AL
J Pediatr Hematol Oncol; 2009 Jan; 31(1):33-7. PubMed ID: 19125084
[TBL] [Abstract][Full Text] [Related]
8. Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy.
Anderson PM; Schroeder G; Skubitz KM
Cancer; 1998 Oct; 83(7):1433-9. PubMed ID: 9762946
[TBL] [Abstract][Full Text] [Related]
9. Patient perceptions about chemotherapy-induced oral mucositis: implications for primary/secondary prophylaxis strategies.
Goldberg SL; Chiang L; Selina N; Hamarman S
Support Care Cancer; 2004 Jul; 12(7):526-30. PubMed ID: 15150704
[TBL] [Abstract][Full Text] [Related]
10. Doxepin rinse versus placebo in the treatment of acute oral mucositis pain in patients receiving head and neck radiotherapy with or without chemotherapy: a phase III, randomized, double-blind trial (NCCTG-N09C6 [Alliance]).
Leenstra JL; Miller RC; Qin R; Martenson JA; Dornfeld KJ; Bearden JD; Puri DR; Stella PJ; Mazurczak MA; Klish MD; Novotny PJ; Foote RL; Loprinzi CL
J Clin Oncol; 2014 May; 32(15):1571-7. PubMed ID: 24733799
[TBL] [Abstract][Full Text] [Related]
11. Severe oral mucositis associated with cancer therapy: impact on oral functional status and quality of life.
Cheng KK; Leung SF; Liang RH; Tai JW; Yeung RM; Thompson DR
Support Care Cancer; 2010 Nov; 18(11):1477-85. PubMed ID: 19916030
[TBL] [Abstract][Full Text] [Related]
12. Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy.
Peterson DE; Barker NP; Akhmadullina LI; Rodionova I; Sherman NZ; Davidenko IS; Rakovskaya GN; Gotovkin EA; Shinkarev SA; Kopp MV; Kulikov EP; Moiseyenko VM; Gertner JM; Firsov I; Tuleneva T; Yarosh A; Woon CW
J Clin Oncol; 2009 Sep; 27(26):4333-8. PubMed ID: 19636011
[TBL] [Abstract][Full Text] [Related]
13. Oral mucositis in paediatric acute lymphoblastic leukemia patients receiving methotrexate-based chemotherapy: case series.
Garrocho-Rangel JA; Herrera-Moncada M; Márquez-Preciado R; Tejeda-Nava F; Ortiz-Zamudio JJ; Pozos-Guillén A
Eur J Paediatr Dent; 2018 Sep; 19(3):239-242. PubMed ID: 30063158
[TBL] [Abstract][Full Text] [Related]
14. The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.
Chaudhry HM; Bruce AJ; Wolf RC; Litzow MR; Hogan WJ; Patnaik MS; Kremers WK; Phillips GL; Hashmi SK
Biol Blood Marrow Transplant; 2016 Apr; 22(4):605-616. PubMed ID: 26409924
[TBL] [Abstract][Full Text] [Related]
15. Low level laser therapy in oral mucositis: a pilot study.
Cauwels RG; Martens LC
Eur Arch Paediatr Dent; 2011 Apr; 12(2):118-23. PubMed ID: 21473845
[TBL] [Abstract][Full Text] [Related]
16. Factors Associated With Oral Mucositis Severity in Children Who Have Received Chemotherapy.
Hurrell L; Burgoyne LL; Logan RM; Revesz T; Gue S
J Pediatr Hematol Oncol; 2022 Nov; 44(8):e1016-e1022. PubMed ID: 35001058
[TBL] [Abstract][Full Text] [Related]
17. The antimicrobial effect of Iseganan HCl oral solution in patients receiving stomatotoxic chemotherapy: analysis from a multicenter, double-blind, placebo-controlled, randomized, phase III clinical trial.
Elad S; Epstein JB; Raber-Durlacher J; Donnelly P; Strahilevitz J
J Oral Pathol Med; 2012 Mar; 41(3):229-34. PubMed ID: 22077420
[TBL] [Abstract][Full Text] [Related]
18. Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy.
Peterson DE; Jones JB; Petit RG
Cancer; 2007 Jan; 109(2):322-31. PubMed ID: 17154160
[TBL] [Abstract][Full Text] [Related]
19. Iseganan HCl: a novel antimicrobial agent.
Giles FJ; Redman R; Yazji S; Bellm L
Expert Opin Investig Drugs; 2002 Aug; 11(8):1161-70. PubMed ID: 12150709
[TBL] [Abstract][Full Text] [Related]
20. Comparison of plain ice and flavoured ice for preventing oral mucositis associated with the use of 5 fluorouracil.
Nikoletti S; Hyde S; Shaw T; Myers H; Kristjanson LJ
J Clin Nurs; 2005 Jul; 14(6):750-3. PubMed ID: 15946283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
